| Multidimensional nature of apomorphine SL (Ixense) therapy. | |
| | |
MedLine Citation:
|
PMID: 12825099 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The aetiology of erectile dysfunction (ED) is multifactorial consisting of psychogenic and organic factors that must be considered in a multidisciplinary manner in order to treat effectively the disorder. New central initiators of erection such as apomorphine SL (Ixense) provide a pharmacologically multidimensional approach to the treatment of ED. When used in conjunction with a psychosexual counselling strategy designed to move patients at high risk of failure to high responder groups, it can provide an effective and safe pharmacological therapy for ED. |
| | |
Authors:
|
P Costa |
Related Documents
:
|
20556699 - [impact of weight-related discrimination on eating disorder and general psychopathology... 20859989 - Evaluation of a guided internet self-treatment programme for bulimia nervosa in several... 16185999 - Eating disorders and irritable bowel syndrome: is there a link? 22632169 - The changing gender gap in substance use disorder: a total population based study of ps... 20440229 - Glucocorticoid receptor gene polymorphisms in italian patients with eating disorders an... 16231349 - Emotional overeating and its associations with eating disorder psychopathology among ov... 16774489 - Practical considerations for carbamazepine use in bipolar disorder. 8339099 - Disordered eating attitudes and behaviors, psychological adjustment, and ethnic identit... 13404439 - Epidemiological basis of malaria control. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: International journal of impotence research Volume: 15 Suppl 2 ISSN: 0955-9930 ISO Abbreviation: Int. J. Impot. Res. Publication Date: 2003 Apr |
Date Detail:
|
Created Date: 2003-06-25 Completed Date: 2004-02-26 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9007383 Medline TA: Int J Impot Res Country: England |
Other Details:
|
Languages: eng Pagination: S13-5 Citation Subset: IM |
Affiliation:
|
Hopital Doumergue 5, rue Hoche, Nimes, France. pierre.costa@chu-nimes.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Apomorphine
/
therapeutic use* Dopamine Agonists / therapeutic use* Erectile Dysfunction / drug therapy*, physiopathology Humans Male Penis / innervation, physiology |
| Chemical | |
Reg. No./Substance:
|
0/Dopamine Agonists; 58-00-4/Apomorphine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evaluating dose regimens of apomorphine, an open-label study.
Next Document: Anxiety and erectile dysfunction: a global approach to ED enhances results and quality of life.